ORIC Pharmaceuticals, Inc. logo ORIC - ORIC Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $20.40 DETAILS
HIGH: $25.00
LOW: $15.00
MEDIAN: $22.00
CONSENSUS: $20.40
UPSIDE: 145.19%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 0 0 0 0 0 0 0 0 0
Cost of Revenue 1.2 1.1 1.0 0 0 0 1 0.9 0.9
Gross Profit (1.2) (1.1) (1.0) 0 0 0 (1) (0.9) (0.9)
Operating Expenses
R&D Expenses 109.8 114.1 85.2 61.7 56.9 60.8 22.8 19.0 19.1
SG&A Expenses 33.2 28.8 25.6 25.1 22.0 13.4 4.7 3.3 2.5
Other Expenses (1.2) (1.1) (1.0) 5 0 0 0 0.2 0
Operating Expenses 141.8 141.8 109.7 91.8 78.9 74.2 27.6 22.4 21.6
Operating Income
Operating Income (143.0) (142.9) (110.8) (91.8) (78.9) (74.2) (28.6) (22.4) (22.5)
Interest Expense 0 0 0 2.6 0 0 0 0 0
Interest Income 0 0 10.1 2.6 0.1 0.3 1.4 0.8 0.3
Profitability
EBITDA (128.2) (126.7) (109.7) (85.8) (78.0) (48.4) (25.9) (20.5) (21.1)
EBIT (129.5) (127.8) (110.8) (86.8) (78.9) (49.3) (26.9) (22.4) (22.5)
Income Before Tax (129.5) (127.8) (100.7) (89.1) (78.7) (73.7) (26.9) (21.4) (22.0)
Income Tax Expense 0 0 0 0 0 0 0 0 0
Net Income (129.5) (127.8) (100.7) (89.1) (78.7) (73.7) (26.9) (21.4) (22.0)
Per Share Data
EPS (Basic) -1.47 -1.83 -1.96 -2.25 -2.07 -3.36 -1.40 -12.32 -15.62
EPS (Diluted) -1.47 -1.83 -1.96 -2.25 -2.07 -3.36 -1.40 -12.32 -15.62
Shares Outstanding 87.8 69.7 51.5 39.7 38.0 21.9 1.9 1.7 1.4
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Current Assets
Cash & Cash Equivalents 45.7 59.4 23.4 66.8 226.0 78.4 89.2 42.6 25.8
Short-Term Investments 235.8 196.6 184.8 139.4 11.0 215.2 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 7.0 6.3 4.4 4.2 0 0 0.8 0 0
Total Current Assets 288.5 262.2 212.6 210.5 240.5 296.7 90.0 43.7 26.6
Non-Current Assets
Property, Plant & Equipment 9.1 2.9 12.0 14.3 2.4 2.0 2.2 2.5 2.9
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long-Term Investments 111.3 0 27.3 22.4 43.4 0 0 0 0
Other Non-Current Assets 0.1 9.0 0.1 0.0 12.3 0.3 1.9 0.5 0.5
Total Non-Current Assets 122.5 11.9 42.1 39.9 58.1 2.3 4.1 3.0 3.4
Total Assets 411.0 274.1 254.7 250.4 298.6 299.0 94.1 46.7 30.0
Current Liabilities
Account Payables 3.8 1.5 0.9 1.3 1.9 0.8 0.2 0.4 0.9
Short-Term Debt 3.3 0 2.8 2.7 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0.5 0.5 0.4 0.4
Other Current Liabilities 13.3 7.6 10.2 6.1 4.8 0 2.8 0.1 0.4
Total Current Liabilities 20.4 24.8 20.5 15.4 15.2 9.0 5.4 2.6 2.6
Non-Current Liabilities
Long-Term Debt 4.1 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 2.1 0 2.7 3.2 0 0 0 0 0
Other Non-Current Liabilities (4.1) 6.2 0 0 10.5 0.2 0 107.3 0
Total Non-Current Liabilities 6.2 6.2 10.1 12.6 10.5 0.2 0.8 108.6 1.7
Total Liabilities 26.6 31.0 30.6 28.0 25.7 9.2 6.1 111.2 4.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (692.2) (562.8) (434.9) (334.2) (245.1) (166.4) (92.7) (65.8) (44.4)
Accumulated Other Comprehensive Income 0.8 0.4 0.3 (1.3) (0.1) (0.0) 0 (2.6) 0
Total Stockholders' Equity 384.4 243.1 224.1 222.4 273.0 289.8 88.0 (64.4) 25.7
Total Liabilities & Equity 411.0 274.1 254.7 250.4 298.6 299.0 94.1 46.7 30.0
Debt Metrics
Total Debt 11.6 3.2 10.2 12.1 1.9 0 0 0 0
Net Debt (34.1) (56.2) (13.2) (54.7) (224.1) (78.4) (89.2) (42.6) (25.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (129.5) (127.8) (100.7) (89.1) (78.7) (73.7) (26.9) (21.4) (22.0)
Depreciation & Amortization 1.2 1.1 1.0 1.0 0.9 1.0 1.0 0.9 0.9
Stock-Based Compensation 0 20.2 15.2 14.5 12.9 5.3 1.1 0.5 0.0
Change in Working Capital (5.5) 2.0 4.9 (0.4) 4.1 2.0 1.2 (0.7) 0.1
Other Non-Cash Items 20.3 (8.1) (6.1) (1.0) 1.4 19.8 0.0 0.0 2.0
Operating Cash Flow (113.4) (112.7) (85.7) (75.1) (59.5) (45.3) (23.5) (20.7) (20.8)
Investing Activities
Capital Expenditure (0.7) (1.2) (0.8) (2.1) (0.9) (0.7) (0.8) (0.5) (0.5)
Acquisitions 0 0 0 2.1 1.4 0 0 0 0
Purchases of Investments (399.8) (251.9) (239.2) (238.1) (69.6) (225.5) 0 0 0
Sales/Maturities of Investments 252.5 275.2 196.7 131.0 229 10 0 0 0
Other Investing Activities 0 0 0 (2.1) (1.4) 0.2 0 0.0 0.2
Investing Cash Flow (148.0) 22.1 (43.4) (109.2) 158.4 (216.0) (0.8) (0.5) (0.3)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 1.5 0.7 0.2 (0.9) (20.8) 0.0 0.1 0
Financing Cash Flow 247.7 126.5 85.7 25.2 49.1 250.5 70.8 38.0 0.3
Cash Position
Net Change in Cash (13.7) 36.0 (43.4) (159.2) 148.0 (10.7) 46.5 16.8 (20.9)
Cash at Beginning 59.9 23.9 67.3 226.5 78.4 89.2 42.6 25.8 46.7
Cash at End 46.2 59.9 23.9 67.3 226.5 78.4 89.2 42.6 25.8
Free Cash Flow (114.1) (113.8) (86.5) (77.2) (60.5) (45.9) (24.3) (21.2) (21.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 0 0 0 0 0 0 0 0 0
Gross Profit (1.2) (1.1) (1.0) 0 0 0 (1) (0.9) (0.9)
Operating Income (143.0) (142.9) (110.8) (91.8) (78.9) (74.2) (28.6) (22.4) (22.5)
Net Income (129.5) (127.8) (100.7) (89.1) (78.7) (73.7) (26.9) (21.4) (22.0)
EPS (Diluted) -1.47 -1.83 -1.96 -2.25 -2.07 -3.36 -1.40 -12.32 -15.62
Balance Sheet
Cash & Equivalents 45.7 59.4 23.4 66.8 226.0 78.4 89.2 42.6 25.8
Total Assets 411.0 274.1 254.7 250.4 298.6 299.0 94.1 46.7 30.0
Total Debt 11.6 3.2 10.2 12.1 1.9 0 0 0 0
Stockholders' Equity 384.4 243.1 224.1 222.4 273.0 289.8 88.0 (64.4) 25.7
Cash Flow
Operating Cash Flow (113.4) (112.7) (85.7) (75.1) (59.5) (45.3) (23.5) (20.7) (20.8)
Capital Expenditure (0.7) (1.2) (0.8) (2.1) (0.9) (0.7) (0.8) (0.5) (0.5)
Free Cash Flow (114.1) (113.8) (86.5) (77.2) (60.5) (45.9) (24.3) (21.2) (21.3)